BayTech Venture Capital
VC
2000
-
München, Bavaria, Germany
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
BayTech Venture Capital was a venture capital firm based in Munich, Germany, founded in 2000. It was an investment arm of Bayerische Landesbank and later acquired by BayernLB Capital Partner. The firm had a team of six people, including two partners, and focused on early-stage investments in technology and life sciences sectors across Western Europe, particularly in Germany and France. BayTech was known for its strategic approach to supporting companies beyond just capital investment.
BayTech Venture Capital primarily invested in Series B rounds, with a focus on sectors such as enterprise applications, high tech, and real estate and construction tech. The firm had a portfolio of 38 investments and 24 exits, with notable investments in companies like Pieris Pharmaceuticals, Open-Xchange, and PandoLogic. BayTech's investments were concentrated in Germany, but it also had a presence in the United States.
Some of BayTech's notable portfolio companies included Pieris Pharmaceuticals - drug discovery, Pandologic - human capital services, EnOcean - other hardware, Ubidyne - connectivity products, and Open-Xchange - business/productivity software. The firm co-invested with other funds, including Gimv, and had a significant impact on the growth and success of its portfolio companies.
